As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/8/24  Cytek Biosciences, Inc.           10-Q        3/31/24  109:9.3M                                   Workiva Inc Wde… FA01/FA 
  5/8/24  Cytek Biosciences, Inc.           8-K:2,9      5/8/24   11:245K                                   Donnelley … Solutions/FA 
 4/25/24  Cytek Biosciences, Inc.           ARS        12/31/23    1:1.9M                                   Broadridge Fin’l So… Inc 
 4/25/24  Cytek Biosciences, Inc.           DEFA14A                1:1.1M                                   Broadridge Fin’l So… Inc 
 4/25/24  Cytek Biosciences, Inc.           DEF 14A      6/5/24   11:5.9M                                   Broadridge Fin’l So… Inc 
 4/23/24  Yan Ming                          4          Dir.,Off.²  1:5K   Cytek Biosciences, Inc.           SEC Connect              
 4/11/24  Yan Ming                          4          Dir.,Off.²  1:5K   Cytek Biosciences, Inc.           SEC Connect              
  4/9/24  Yan Ming                          144                    1:6K   Cytek Biosciences, Inc.           Morgan Stanley … Svcs/FA 
 3/21/24  Busque Philippe                   4          Officer²    1:7K   Cytek Biosciences, Inc.           SEC Connect              
 3/20/24  McCombe William D.                3          Officer²    2:9K   Cytek Biosciences, Inc.           SEC Connect              
 3/19/24  Yan Ming                          4          Dir.,Off.²  1:6K   Cytek Biosciences, Inc.           SEC Connect              
 3/19/24  Cytek Biosciences, Inc.           8-K:5,9     3/17/24   12:211K                                   Donnelley … Solutions/FA 
 3/18/24  Yan Ming                          144                    1:5K   Cytek Biosciences, Inc.           Morgan Stanley … Svcs/FA 
 3/14/24  Cytek Biosciences, Inc.           S-8         3/14/24    4:85K                                    Donnelley … Solutions/FA 
 3/13/24  Yan Ming                          4          Dir.,Off.²  1:7K   Cytek Biosciences, Inc.           SEC Connect              
 3/13/24  Williams Paul Christopher         4          Officer²    1:7K   Cytek Biosciences, Inc.           SEC Connect              
 3/13/24  Poirson Allen                     4          Officer²    1:7K   Cytek Biosciences, Inc.           SEC Connect              
 3/13/24  Jiang Wenbin                      4          Dir.,Off.²  1:7K   Cytek Biosciences, Inc.           SEC Connect              
 3/13/24  Jeanmonod Patrik                  4          Officer²    1:7K   Cytek Biosciences, Inc.           SEC Connect              
 3/13/24  Barnett Valerie                   4          Officer²    1:7K   Cytek Biosciences, Inc.           SEC Connect              

____________
¹	Filing/Form Types:  /A
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-Q	Quarterly Report — Form 10-Q.
	144	Notice of a Proposed Sale of Securities by an Insider — Form 144 { The Filer is an Insider² of the Issuer }.
	ARS	Annual Report to Security Holders.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	DEFA14A	Definitive Additional Proxy Soliciting Material — Schedule 14A.
	S-8	Registration Statement – Securities for an Employee Benefit Plan — Form S-8.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.